NOMAS is a prospective cohort study designed to measure cardiovascular risk factors and outcomes in a stroke-free population. Participants were recruited during annual follow-up to undergo a brain magnetic resonance imaging (MRI) if they were free of clinical stroke, aged ≥50 years, and had no contraindications to MRI. Our study sample consisted of 1075 eligible participants who had lived at the same address for at least 2 years before MRI. Detailed Methods are provided in the online-only Data Supplement.
S
ubclinical cerebrovascular disease is an important contributor to disability and functional decline. The prevalence of subclinical cerebrovascular disease is high in the elderly population and has been associated with an increased risk of stroke, cognitive decline and dementia, and mortality. [1] [2] [3] [4] Identification of modifiable risk factors is, therefore, of great importance.
Long-term exposure to ambient air pollution is an established risk factor for cardiovascular and cerebrovascular morbidity and mortality, with pollution from traffic seemingly particularly important. [5] [6] [7] However, few studies have assessed long-term pollution as a modifiable risk factor for subclinical cerebrovascular disease. [8] [9] [10] [11] We evaluated this relationship in NOMAS (the Northern Manhattan Study), and hypothesizing the prevalence of subclinical cerebrovascular disease would be greater among individuals exposed to higher levels of longterm ambient air pollution.
and Air Pollution). 12 Residential distance to the nearest major roadway was calculated as a secondary marker of exposure to traffic pollution and modeled as a natural log-transformed continuous variable.
Imaging for subclinical cerebrovascular disease was performed on a 1.5-T MRI system. White matter hyperintensity volume (WMHV) and total cerebral brain volume (TCBV) were expressed as the proportion of total cranial volume and analyzed as continuous measures. WMHV was log transformed to create a normal distribution (log-WMHV). The presence or absence of subclinical brain infarcts (SBI) was defined using size, location, and imaging characteristics. Lesions ≥3 mm were considered infarcts.
Linear and logistic regression models were used to estimate the association and 95% confidence intervals between markers of pollution and log-WMHV, TCBV, and SBI. We present results from unadjusted models (model 1), models adjusted for sociodemographic characteristics (model 2), and further adjusted for cardiovascular risk factors and year of MRI (model 3).
Results
Mean age of participants at MRI was 71.2 years; 62% were women. Characteristics of the study sample are detailed in the Table I in the online-only Data Supplement. Pollution averages were similar regardless of averaging duration; therefore, 1-year pollution averages were used for all analyses (Table II in the online-only Data Supplement).
There was no evidence of an association between other pollutants and log-WMHV (Table) . Pollutant levels were not significantly associated with TCBV or SBI (Table) . In unadjusted models, residential distance to nearest major roadway was associated with a higher log-WMHV (Table) , contrary to our expectations. This association was attenuated and no longer significant after adjustment for socioeconomic and cardiovascular risk factors.
Results were similar regardless of pollutant-averaging period (Table III in the online-only Data Supplement); modeling pollutant levels using quartiles did not materially change the results (not shown). A similar pattern of association was observed with categorical definitions of distance to roadways (Table IV in the online-only Data Supplement).
Discussion
Contrary to our hypothesis, we did not find evidence supportive of an association between long-term levels of ambient air pollution and subclinical cerebrovascular disease. Prior studies have reported heterogeneous results. For example, in the Framingham Offspring Cohort, long-term PM 2.5 was associated with higher odds of SBI but not of WMHV. 8 In the Cardiovascular Health Study, PM 10 was associated with higher 
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risk of vascular dementia and worse WMHV but not of SBI. 10 In the Massachusetts Alzheimer's Disease Research Center Longitudinal Cohort, PM 2.5 was paradoxically associated with lower WMHV. 11 Studies considering cerebral brain volumes have been more consistent, with an inverse association observed between PM 2.5 and white matter volume in the Women's Health Initiative Memory Study 9 and between PM 2.5 and TCBV in Framingham Offspring Cohort participants. 8 In this study, we found a modest inverse association between PM 2.5 and TCBV although this result was not statistically significant.
Our study was potentially limited by the small geographic extent of the study area. However, the variability of our exposures was comparable to that seen in several other studies reporting statistically significant findings 8 and therefore likely did not substantially limit our ability to detect meaningful associations. Another limitation is that our pollution estimates did not account for housing characteristics or time-activity patterns. However, MESA-Air estimates have been previously validated, and associations with other health outcomes have been observed. 7, 13 Last, our sample may have been healthier than the overall population of NOMAS because of the selection criteria of the MRI cohort, limiting the generalizability of our results.
Our study had several strengths. We assessed individuallevel estimates of air pollution for various time durations to get a full picture of the influence of air pollution on the cerebrovascular health of an aging urban population. We used the heterogeneous NOMAS population with well-documented study methodology and ascertainment of clinical risk factors and outcome measures. In addition, our analysis had a larger sample size than most prior studies. In conclusion, we found no evidence suggesting that long-term exposure to ambient air pollution is associated with subclinical cerebrovascular disease. Furthermore, large-scale studies with well-defined pollution exposure measures are needed to confirm or refute these findings.
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